Clostridium bacteraemia characterised by 16S ribosomal RNA gene sequencing.
BACKGROUND
Owing to problems in accurate species identification of the diverse genus clostridium, the epidemiology and pathogenicity of many species are not fully understood. Moreover, previous studies on clostridium bacteraemia have been limited and relied only on phenotypic species identification.


OBJECTIVE
To characterise the epidemiology, disease spectrum, and outcome of clostridium bacteraemia using 16S ribosomal RNA (rRNA) gene sequencing.


METHODS
During a four year period (1998-2001), all cases of clostridium bacteraemia were prospectively studied and all "non-perfringens" clostridium isolates identified to the species level by 16S rRNA gene sequencing.


RESULTS
Fifty one blood culture isolates were identified as Clostridium perfringens and 17 belonged to 11 other clostridium species. The first case of C disporicum infection and two cases of clostridium bacteraemia in children with intussusception were also described. Of the 68 clostridium isolates from 68 different patients, 38 were associated with clinically relevant bacteraemia. The gastrointestinal and hepatobiliary tracts were common sites of both underlying disease and portal of entry in these patients. Clostridium perfringens accounted for 79% of all clinically relevant bacteraemia, with the remainder caused by a diversity of species. The attributable mortality rate of clinically relevant clostridium bacteraemia was 29%. Younger age and underlying gastrointestinal/hepatobiliary tract disease were associated with mortality (p < 0.05).


CONCLUSIONS
Patients with clinically relevant clostridium bacteraemia should be investigated for the presence of underlying disease processes in the gastrointestinal or hepatobiliary tracts. 16S rRNA gene analysis will continue to be useful in further understanding the pathogenicity of various clostridium species.
Woo
P C Y
PC
Department of Microbiology, University Pathology Building, Queen Mary Hospital, Pokfulam Road, Hong Kong, China.
Lau
S K P
SK
Chan
K-M
KM
Fung
A M Y
AM
Tang
B S F
BS
Yuen
K-Y
KY
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016470:Bacteremia / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology*; D015373:Bacterial Typing Techniques / Q000379:methods; D002648:Child; D003013:Clostridium / Q000145:classification* / Q000302:isolation & purification / Q000472:pathogenicity; D003015:Clostridium Infections / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology*; D003016:Clostridium perfringens / Q000145:classification / Q000302:isolation & purification; D005260:Female; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods; D011446:Prospective Studies; D012329:RNA, Bacterial / Q000235:genetics*; D012336:RNA, Ribosomal, 16S / Q000235:genetics*; D012307:Risk Factors; D017423:Sequence Analysis, RNA / Q000379:methods; D016019:Survival Analysis
D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S
Int J Syst Evol Microbiol. 2003 Jul;53(Pt 4):1019-29
12892121
Scand J Infect Dis. 2000;32(1):27-30
10716073
Int J Syst Bacteriol. 1994 Oct;44(4):812-26
7981107
Hong Kong Med J. 1997 Sep;3(3):302-304
11847376
J Microbiol Immunol Infect. 2001 Jun;34(2):113-8
11456356
FEMS Immunol Med Microbiol. 1999 Jul;24(3):253-8
10397308
J Pediatr Gastroenterol Nutr. 2001 Sep;33(3):289, 300
11601434
Int J Syst Evol Microbiol. 2002 May;52(Pt 3):801-7
12054241
Int J Syst Evol Microbiol. 2000 Jan;50 Pt 1:101-6
10826792
Clin Infect Dis. 2001 Aug 1;33(3):349-53
11438901
Int J Infect Dis. 2002 Mar;6(1):69-73
12044306
N Engl J Med. 1990 Dec 6;323(23):1573-80
2233945
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
7984417
J Clin Microbiol. 2001 Dec;39(12):4227-32
11724825
N Engl J Med. 1992 Jul 30;327(5):293-301
1377787
Clin Infect Dis. 1997 Apr;24(4):584-602
9145732